Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
BackgroundThe appropriate age range for breast cancer screening remains a matter of debate. We aimed to estimate the effect of mammographic screening at ages 40–48 years on breast cancer mortality.MethodsWe did a randomised, controlled trial involving 23 breast screening units across Great Britain....
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | Stephen W. Duffy, Daniel Vulkan, Howard Cuckle, Dharmishta Parmar, Shama Sheikh, Robert A. Smith, Andrew Evans, Oleg Blyuss, Louise Johns, Ian O. Ellis, Jonathan P. Myles, Peter Sasieni, Sue Moss |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Αγγλικά |
Έκδοση: |
2020
|
Διαθέσιμο Online: | https://doi.org/10.1016/s1470-2045(20)30398-3 http://www.thelancet.com/article/S1470204520303983/pdf |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
από: Duffy, Stephen W, κ.ά.
Έκδοση: (2020) -
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
από: Duffy, Stephen, κ.ά.
Έκδοση: (2020) -
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
από: Stephen W. Duffy, κ.ά.
Έκδοση: (2020) -
False-positive results in the randomised controlled trial of mammographic screening from age 40 (‘Age’ trial)
από: Johns, Louise E, κ.ά.
Έκδοση: (2010) -
Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial
από: Sue Moss, κ.ά.
Έκδοση: (2015)